Butylamine

Butylamine

SCHEMBL9108656

CCCC(c1ccccc1)c1ccc(O)cc1.CCCCN

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.55
HTR2A P28223 3/20 0.55
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
ESR1 P03372 4/20 0.42
ESR2 Q92731 2/20 0.42
AOC3 Q16853 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
CYP19A1 P11511 1/20 0.40
LMNA P02545 3/20 0.40
HSD17B10 Q99714 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MITF O75030 1/20 0.39
CYP1A2 P05177 1/20 0.39
PGR P06401 1/20 0.39
CHRM2 P08172 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butylamine SCHEMBL9108736 0.90 HRH1 (0.67) HRH1HTR2AAOC3SIGMAR1LMNA
SCHEMBL1973610 0.88 ESR1 (0.52) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL7517085 0.84 SIGMAR1 (0.50) HRH1HTR2ACNR1CNR2ESR1
Tert-Butylamine SCHEMBL9107540 0.83 CNR1 (0.45) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL27460165 0.83 SIGMAR1 (0.53) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL69257 0.82 ESR1 (0.57) CNR1CNR2ESR1ESR2MEN1
Benzylamine SCHEMBL9392739 0.82 ABAT (0.48) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL28822870 0.81 SIGMAR1 (0.51) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL14288442 0.81 SIGMAR1 (0.51) HRH1HTR2ACNR1CNR2ESR1
SCHEMBL28035908 0.81 SIGMAR1 (0.51) HRH1HTR2ACNR1CNR2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995010269-A1 TREATMENT OF URINARY INCONTINENCE AND OTHER DISORDERS WITH R-TERODILINE AND HYDROXYLATED DERIVATIVES THEREOF SEPRACOR, INC. (US) 1995-04-20 WO claimed
WO-1995010270-A1 METHOD FOR TREATING URINARY INCONTINENCE USING OPTICALLY PURE S-TERODILINE SEPRACOR, INC. (US) 1995-04-20 WO claimed
WO-1995010270-A1 METHOD FOR TREATING URINARY INCONTINENCE USING OPTICALLY PURE S-TERODILINE SEPRACOR, INC. (US) 1995-04-20 WO disclosed
WO-1995010269-A1 TREATMENT OF URINARY INCONTINENCE AND OTHER DISORDERS WITH R-TERODILINE AND HYDROXYLATED DERIVATIVES THEREOF SEPRACOR, INC. (US) 1995-04-20 WO disclosed